EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran


Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran



Acta Medica Austriaca 18(Suppl 1): 27-29



ISSN/ISBN: 0303-8173

PMID: 1719730

Hemodilution is often recommended for peripheral arterial occlusive disease, yet the ultimate proof of efficacy is lacking in two randomized, placebo-controlled, double-blind, crossover trials (one using Dextran 40 and the other 10% hydroxyethyl starch 200) it has been shown to clinically benefit claudicants. During the hemodilution phases of these trials, where a 500 ml volume was exchanged against 500 ml blood, there was a significant prolongation of the walking distances. With sham-hemodilution there were no beneficial effects. These studies suggest furthermore that responders and non-responders to hemodilution can be identified prior to therapy by angiogram. A theory is developed which implies that low shear forces in vivo are a precondition for the clinical effectiveness of hemodilution. The experimental evidence supporting this theory is reported. Dextran and hydroxyethyl starch do not seem to differ with respect to their clinical response. It is concluded that hemodilution is effective for peripheral arterial occlusive disease stage II and probably even more effective in more advanced stages.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040262938

Download citation: RISBibTeXText

Related references

Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution. Klinische Wochenschrift 65(7): 324-330, 1987

Isovolemic hemodilution in stage-IIb peripheral arterial occlusive diseases. Prospective randomized double-blind comparison of middle-molecule hydroxyethyl starch and electrolyte solution. Deutsche Medizinische Wochenschrift 111(35): 1307-1312, 1986

Placebo-controlled, double-blind trial of hemodilution in peripheral occlusive arterial disease. International College of Angiology. Annual Meeting 30 (1988) 40(5): 479-483, 1989

Placebo-controlled, double-blind trial of hemodilution in peripheral occlusive arterial disease. Angiology 40(5): 479-483, 1989

Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline. Angiology 40(7): 639-649, 1989

Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study. Deutsche Medizinische Wochenschrift 112(22): 873-878, 1987

Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial. Circulation 105(22): 2646-2652, 2002

Placebo-controlled, double-blind study of haemodilution in peripheral arterial disease. Lancet 1(8548): 1449-1451, 1987

Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease. Wiener Medizinische Wochenschrift 139(17): 396-401, 1989

Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care 26(9): 2575-2580, 2003

A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease. International Journal of Clinical Pharmacology Therapy and Toxicology 28(5): 197-204, 1990

A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease. International Journal of Clinical Pharmacology, Therapy and Toxicology (1980) 28(5): 197-204, 1990

Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb. Journal of Internal Medicine 227(2): 107-114, 1990

Hypervolemic hemodilution with hydroxyethyl starch influence of application time on viscoelasticity of blood in peripheral arterial occlusive disease stage iia and iib. Acta Medica Austriaca 18(SPEC ISSUE 1): 45-47, 1991

Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease. Acta Medica Austriaca 18(Suppl 1): 45-47, 1991